NO893256L - Fremgangsmaate for fremstilling av furyltiazolderivater. - Google Patents

Fremgangsmaate for fremstilling av furyltiazolderivater.

Info

Publication number
NO893256L
NO893256L NO89893256A NO893256A NO893256L NO 893256 L NO893256 L NO 893256L NO 89893256 A NO89893256 A NO 89893256A NO 893256 A NO893256 A NO 893256A NO 893256 L NO893256 L NO 893256L
Authority
NO
Norway
Prior art keywords
preparation
derivatives
furyltiazold
procedure
ulcer
Prior art date
Application number
NO89893256A
Other languages
English (en)
Norwegian (no)
Other versions
NO893256D0 (no
Inventor
Hisashi Takasugi
Yousuke Katsura
Yoshikazu Inoue
Tetsuo Tomishi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819365A external-priority patent/GB8819365D0/en
Priority claimed from GB898905818A external-priority patent/GB8905818D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO893256D0 publication Critical patent/NO893256D0/no
Publication of NO893256L publication Critical patent/NO893256L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO89893256A 1988-08-15 1989-08-14 Fremgangsmaate for fremstilling av furyltiazolderivater. NO893256L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819365A GB8819365D0 (en) 1988-08-15 1988-08-15 New furylthiazole derivatives processes for preparation thereof & pharmaceutical composition comprising same
GB898905818A GB8905818D0 (en) 1989-03-14 1989-03-14 New furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
NO893256D0 NO893256D0 (no) 1989-08-14
NO893256L true NO893256L (no) 1990-02-16

Family

ID=26294284

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893256A NO893256L (no) 1988-08-15 1989-08-14 Fremgangsmaate for fremstilling av furyltiazolderivater.

Country Status (12)

Country Link
EP (1) EP0355612B1 (fi)
JP (1) JP2814594B2 (fi)
KR (1) KR900003166A (fi)
CN (1) CN1040796A (fi)
AT (1) ATE109144T1 (fi)
AU (1) AU3934689A (fi)
DE (1) DE68917049T2 (fi)
DK (1) DK391089A (fi)
FI (1) FI893795A (fi)
IL (1) IL91152A0 (fi)
NO (1) NO893256L (fi)
PT (1) PT91415B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
US5512588A (en) * 1991-08-02 1996-04-30 Fujisawa Pharmaceutical Co., Ltd. Furylthiazoles and their use as H2 - receptor antagonists and antimicrobials
GB9211163D0 (en) * 1992-05-26 1992-07-08 Fujisawa Pharmaceutical Co New oxazole derivatives
GB9326611D0 (en) * 1993-12-31 1994-03-02 Fujisawa Pharmaceutical Co New compound
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
JPWO2016098793A1 (ja) * 2014-12-17 2017-09-28 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2961923D1 (en) * 1978-01-18 1982-03-11 Ici Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS5936674A (ja) * 1982-08-25 1984-02-28 Yamanouchi Pharmaceut Co Ltd Ｎ−置換グアニジノチアゾ−ル誘導体およびその製造法
JPS59225186A (ja) * 1983-05-18 1984-12-18 Yamanouchi Pharmaceut Co Ltd 新規なグアニジノチアゾ−ル誘導体及びその製造方法
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPS62273977A (ja) * 1986-05-21 1987-11-28 Yoshitomi Pharmaceut Ind Ltd フリルチアゾ−ル化合物
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents

Also Published As

Publication number Publication date
JP2814594B2 (ja) 1998-10-22
IL91152A0 (en) 1990-03-19
DK391089D0 (da) 1989-08-09
DK391089A (da) 1990-02-16
FI893795A (fi) 1990-02-16
JPH0272177A (ja) 1990-03-12
KR900003166A (ko) 1990-03-23
EP0355612A2 (en) 1990-02-28
PT91415B (pt) 1995-05-04
NO893256D0 (no) 1989-08-14
EP0355612A3 (en) 1990-08-22
AU3934689A (en) 1990-02-15
DE68917049T2 (de) 1995-01-05
CN1040796A (zh) 1990-03-28
PT91415A (pt) 1990-03-08
FI893795A0 (fi) 1989-08-11
ATE109144T1 (de) 1994-08-15
DE68917049D1 (de) 1994-09-01
EP0355612B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
DK275585A (da) Hidtil ukendte calciumsalte
NO874955D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
DK393188A (da) Farmaceutisk praeparat til intranasal administrering
NO862534L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
ATE88084T1 (de) Verwendung eines gemisches zur behandlung der alopezie.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO902710L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater.
NO167456C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
NO880292L (no) Fremgangsmaate for behandling av humle.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
RU92016264A (ru) Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
NO900616L (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.